Anavex Life Sciences
Daniel Klamer, PhD, MBA is the Vice President of Business Development & Scientific Strategy at Anavex Life Sciences. With a background in pharmacology and neuroscience, Daniel has played key roles in various companies, from co-founding startups to leading research projects. Known for their expertise in drug development and commercialization, Daniel has made significant contributions to the field of neurodegenerative and neurodevelopmental diseases.
This person is not in the org chart
Anavex Life Sciences
Anavex Life Sciences Corp.(www.anavex.com) is a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodevelopmental and neurodegenerative diseases. Anavex is currently in a Phase 2a trial for Alzhei...